HAIFA, Israel, December 3 /PRNewswire/ -- Cardio Vascular Medical Device Corp. (CVSL.OB), a leading developer of advanced cardiovascular surgery technology, today announced that the Company is considering a listing on a European exchange due to growing demand from foreign investors and to further coordinate marketing efforts in Europe. The Company is now in discussions with various exchanges to determine the best alternative for its shareholders.
“Listing our company on an exchange in Europe will help to grow our shareholder base and better enable us to seek capital as well as marketing opportunities abroad,” stated Eli Gonen, CEO of Cardio Vascular Medical Device Corp. “We have already received great interest from various parties in Europe for our patented guidewire, and are confident that our proprietary technology can aid in the performance of angioplasty procedures in developed countries across the world.”
About Cardio Vascular Medical Device
Cardio Vascular Medical Device holds a US patent for an innovative next-generation “steerable guidewire” applicable for all angioplasty (PCTA) procedures. The technology hinges on a bendable tip that improves guidewire performance, enables faster procedure completion, and provides cost benefits for patients as well as healthcare providers. The guidewire has a unique opportunity to become the guidewire of choice for surgeons throughout the world.
Learn more about Cardio Vascular Medical Device at: http://www.cvslmedical.com
Forward-Looking Statements
This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of Cardio Vascular Medical Device Corp. and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated in the forward-looking statements. Cardio Vascular Medical Device Corp. public filings may be viewed at http://www.sec.gov.
CONTACT: Contact: Alex Traiman, Media Relations, +1-646-863-9729, Asher
Zwebner, +972-54-464-6363, asher@fxmng.com
